Editorial: FGF21 as a therapeutic target for obesity and insulin resistance: from rodent models to humans.
Saved in:
| Title: | Editorial: FGF21 as a therapeutic target for obesity and insulin resistance: from rodent models to humans. |
|---|---|
| Authors: | De Sousa-Coelho AL; Escola Superior de Saúde (ESS), Universidade do Algarve (UAlg), Faro, Portugal.; Algarve Biomedical Center Research Institute (ABC-RI), Universidade do Algarve (UAlg), Faro, Portugal.; Algarve Biomedical Center (ABC), Faro, Portugal., Rodriguez-Rodriguez R; Basic Sciences Department, Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain., Softic S; Department of Pediatrics, Division of Pediatric Gastroenterology, Kentucky Children's Hospital, and Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY, United States., Jonker JW; Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands., Relat J; Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.; Department of Nutrition, Food Sciences and Gastronomy, School of Pharmacy and Food Sciences, University of Barcelona, Santa Coloma de Gramenet, Spain.; Institute of Nutrition and Food Safety of the University of Barcelona (INSA-UB), Santa Coloma de Gramenet, Spain. |
| Source: | Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2023 Aug 07; Vol. 14, pp. 1253675. Date of Electronic Publication: 2023 Aug 07 (Print Publication: 2023). |
| Publication Type: | Editorial |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37608789 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Editorial: FGF21 as a therapeutic target for obesity and insulin resistance: from rodent models to humans. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22De+Sousa-Coelho+AL%22">De Sousa-Coelho AL</searchLink>; Escola Superior de Saúde (ESS), Universidade do Algarve (UAlg), Faro, Portugal.; Algarve Biomedical Center Research Institute (ABC-RI), Universidade do Algarve (UAlg), Faro, Portugal.; Algarve Biomedical Center (ABC), Faro, Portugal.<br /><searchLink fieldCode="AU" term="%22Rodriguez-Rodriguez+R%22">Rodriguez-Rodriguez R</searchLink>; Basic Sciences Department, Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Softic+S%22">Softic S</searchLink>; Department of Pediatrics, Division of Pediatric Gastroenterology, Kentucky Children's Hospital, and Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY, United States.<br /><searchLink fieldCode="AU" term="%22Jonker+JW%22">Jonker JW</searchLink>; Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.<br /><searchLink fieldCode="AU" term="%22Relat+J%22">Relat J</searchLink>; Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.; Department of Nutrition, Food Sciences and Gastronomy, School of Pharmacy and Food Sciences, University of Barcelona, Santa Coloma de Gramenet, Spain.; Institute of Nutrition and Food Safety of the University of Barcelona (INSA-UB), Santa Coloma de Gramenet, Spain. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101555782%22">Frontiers in endocrinology</searchLink> [Front Endocrinol (Lausanne)] 2023 Aug 07; Vol. 14, pp. 1253675. <i>Date of Electronic Publication: </i>2023 Aug 07 (<i>Print Publication: </i>2023). – Name: TypePub Label: Publication Type Group: TypPub Data: Editorial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101555782 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1664-2392 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216642392%22">16642392 </searchLink><i>NLM ISO Abbreviation: </i>Front Endocrinol (Lausanne) <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37608789 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fendo.2023.1253675 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1253675 Titles: – TitleFull: Editorial: FGF21 as a therapeutic target for obesity and insulin resistance: from rodent models to humans. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: De Sousa-Coelho AL – PersonEntity: Name: NameFull: Rodriguez-Rodriguez R – PersonEntity: Name: NameFull: Softic S – PersonEntity: Name: NameFull: Jonker JW – PersonEntity: Name: NameFull: Relat J IsPartOfRelationships: – BibEntity: Dates: – D: 07 M: 08 Text: 2023 Aug 07 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 1664-2392 Numbering: – Type: volume Value: 14 Titles: – TitleFull: Frontiers in endocrinology Type: main |
| ResultId | 1 |
